CLB Core Laboratories N.V.
889
$17.00
$0.09
(0.53%)
| Watchers | 889 |
| 52-Wk Low | $13.82 |
| 52-Wk High | $27.95 |
| Market Cap | $797.3M |
| Volume | 421,327.00 |
| 52-Wk High | $27.95 |
| 52-Wk Low | $13.82 |
FY2025 EPS Estimates for Core Laboratories Inc. Raised by Zacks Research (NYSE:CLB)Zolmax • about 1 month ago
Core Laboratories Inc. (NYSE:CLB - Free Report) - Equities researchers at Zacks Research upped their FY2025 earnings per share estimates for shares of Core Laboratories in a research report issued...
Share to Feed
Core Laboratories Inc. (NYSE:CLB Free Report) Research analysts at Zacks Research boosted their Q4 2024 EPS estimates for Core Laboratories in a note issued to investors on Tuesday...
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.The research service...
This is a signal that CLB's price could be shifting from an uptrend to a downtrend. Traders may consider selling the stock or exploring put options...
This is a signal that CLB's price could be shifting from an uptrend to a downtrend. Traders may consider selling the stock or exploring put options...
Core Laboratories Inc. (NYSE:CLB Get Free Report) has been assigned an average recommendation of Reduce from the four ratings firms that are covering the stock, Marketbeat...
This is a signal that CLB's price could be shifting from an uptrend to a downtrend. Traders may consider selling the stock or exploring put options...
This is a signal that CLB's price could be shifting from an uptrend to a downtrend. Traders may consider selling the stock or exploring put options...
This is a signal that CLB's price could be shifting from an uptrend to a downtrend. Traders may consider selling the stock or exploring put options...
Core Laboratories Inc. (NYSE:CLB Free Report) Analysts at Zacks Research cut their Q1 2024 earnings per share (EPS) estimates for Core Laboratories in a note issued to investors on...